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Our laboratory is blending new RNA chemistries, largely
directed at the ribose 2’-hydroxyl group, with quantita-
tive interpretation to create new kinds of chemical
microscopes for accurate RNA structure analysis. This
seminar will focus on two examples from retroviral biol-
ogy. All retroviral RNAs contain a packaging element
that directs the genome into nascent virus particles
through a mechanism that has been unclear. Using
SHAPE, we probed the structure of murine leukemia
virus RNA inside virus particles and identified the bind-
ing site for the nucleocapsid domain of Gag. The RNA
structural context is critical: High-affinity binding
requires two specific UCUG-UR-UCUG motifs flanked
by base-paired elements. Mutation of four guanosine
residues in these two motifs - only 4 nucleotides per
genomic RNA - reduced packaging to non-specific
levels. These motifs only form in genomic RNA dimers;
thus analysis of authentic full-length RNA was critical.
This work illustrates how local context and RNA struc-
ture can create information-rich recognition signals
from simple single-stranded sequence elements. In the
second example, we discovered strong correlations
between shRNA-mediated inhibition of HIV-1 replica-
tion in a cell-based assay and both the energetic cost of
breaking secondary structures and the overall annealing
energy between guide strand and folded target RNA.
These correlations were only apparent when the ener-
getic cost of disrupting pre-existing structure in the
HIV-1 RNA was calculated using a secondary structure
model derived from SHAPE probing information. We
verified these correlations by design and evaluation of
additional shRNAs and could achieve consistent inhibi-
tion of HIV-1 production by 90%. This approach
emphasizes the profound, but ultimately predictable,
role of RNA structure in tuning RNAi function and is
likely to prove broadly useful in understanding large-
scale biological recognition involving RNA.
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